PRE 14A

FORM PRE 14A

Company: NovaBay Pharmaceuticals, Inc.
Filed: August 30, 2019
Period of Report: October 9, 2019
Accession Number: 0001437749-19-017705

View Document ↗ View on SEC.gov ↗